Converting melanoma-associated fibroblasts into a tumor-suppressive phenotype by increasing intracellular Notch1

Hongwei Shao1, Mecker Moller1, Long Cai1

  • 1Department of Surgery, University of Miami School of Medicine, Miami, Florida, United States of America.

Plos One
|March 11, 2021
PubMed

Insights

Melanoma-associated fibroblasts (MAFs) show reduced Notch signaling. Activating this pathway in MAFs inhibits melanoma growth and tumor angiogenesis, offering a potential new therapy.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Cancer-associated fibroblasts (CAFs) influence tumor progression, drug resistance, and recurrence.
  • The Notch pathway's role in CAFs' tumor-regulatory function has been previously established.
  • Melanoma-associated fibroblasts (MAFs) are a specific subtype of CAFs found in melanoma.

Purpose of the Study:

  • To investigate Notch signaling status in human MAFs compared to normal fibroblasts.
  • To determine if manipulating Notch pathway activity in MAFs affects their tumor-regulatory function.
  • To explore the therapeutic potential of targeting Notch signaling in MAFs for melanoma treatment.

Main Methods:

  • Analysis of Notch pathway activity in MAFs and normal fibroblasts using tissue microarrays.
  • Isolation and co-culture of MAFs and melanoma cells in vitro.
  • In vivo studies using a mouse co-graft model to assess melanoma growth and angiogenesis.

Main Results:

  • MAFs exhibit significantly decreased Notch pathway activity compared to normal fibroblasts.
  • Activation of the Notch pathway in MAFs suppressed melanoma cell growth in vitro.
  • In vivo, Notch pathway activation in MAFs restricted melanoma skin growth and reduced tumor angiogenesis.

Conclusions:

  • Notch signaling is demonstrably inhibited in MAFs.
  • Enhancing Notch pathway activity in MAFs can induce tumor-suppressive functions.
  • Targeting Notch signaling in MAFs presents a novel therapeutic strategy for melanoma.